维普中文期刊产品整合服务
23篇 您的检索式:作者名="GALATI R"
    题名 作者 年代 出处 被引量
1Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:3
2Prognostic value of left ventric- ular volume response during dobutamine stress echocardiography 显示文摘Coletta C Galati A Ricci R 1997Eur Heart J1997,18,10:1
3Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure 显示文摘Verdina A Galati R Falasca G 2001J Toxicol Environ Health A2001,64,:1
4Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
5Diagnostic strategies to investigate cerebrospinal fluid involvement in haematologlcal malignancies显示文摘Galati D Di Noto R Del Vchio L 2013Leuk Res2013,37,3:1
6Thermal Effects on Bond between FRP Rebars and Concrete显示文摘Galati N Nanni A Dharani R L Focacci F Aiello A M 2006Composites-Part A: Applied Science and Manufacturing2006,37,08:1
7Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
8Analysis and Compari- son of Two Order Statistics CFAR Systems显示文摘Di Vito A Galati G Mura R 1994IEE Proceedings Radar Sonar and Navigation1994,141,2:1
9Metabolic polymorphisms and urinary blomarkers in subjects with low benzene exposure 显示文摘VERDINA A GALATI R FALASCA G 2001J Toxicol Enviro Health Part A2001,64,8:1
10Thermal effects onbond between FRP rebars and concrete显示文摘Galati N Nanni A Dharani L R 2006Composites Part A:Applied Science and Manufacturing2006,37,8:1
11Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patient with knee osteoarthritis显示文摘Morreale P Manopulo R Galati M 1996Rheumatol1996,23,8:1
12Alliance and Networks 显示文摘Galati R 1998Strategic Management Journal1998,,19:1
13Alliance and Networks 显示文摘Galati R 1998Strategic Management Journal1998,,19:1
14Effect of Opuntia ficus indica (L) Mill cladodes in the woundhealing process显示文摘Galati E M Mondello M R Monforte M T 2003J Profess Assoc Cactus Develop2003,,5:1
15Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure 显示文摘Ve Mina A Galati R Falasca G 2001Toxicol Environ Health2001,64,:1
16Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patient with knee osteoarthritis显示文摘Morreale P Manopulo R Galati M 1996Rheumatol1996,23,8:1
17Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure显示文摘Verdina A Galati R Falasca G 2001J Toxicol Environ Health A2001,64,:1
18Alliances and Networks显示文摘Galati R 1998Strategic Management Journal1998,,19:1
19Association of maternal and nutrient supply line factors with DNA methylation at the imprinted IGF2/H19 locus in multiple tissues of newborn twins显示文摘Loke YJ Galati JC Morley R 2013Epigenetics2013,8,10:1
20Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford 2010The Lancet2010,,9742:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费